WASHINGTON, D.C. (March 18, 2010) — The National Osteoporosis Foundation (NOF) announces its participation in the Osteoporosis Exchange on WebMD. The Exchange is featured in the new WebMD Health Exchange, a health social networking platform that provides a unique way for consumers to get health and wellness support from the world’s largest community of online health-informed consumers. The WebMD Health Exchange was developed to engage consumers on a variety of health and wellness topics, including osteoporosis. It gives consumers the ability to connect with world-class health experts and other WebMD members to exchange real experiences, discuss personal challenges and receive direct answers and support.
The WebMD Health Exchange will connect consumers with the knowledge and credibility of leading professionals from renowned health and medical organizations and patient advocacy groups. The WebMD Osteoporosis Exchange will give NOF a presence on WebMD, the leading online source of health information for consumers and healthcare professionals. More than 60 million consumers visit the WebMD Health Network each month. The WebMD Osteoporosis Exchange will feature NOF affiliated healthcare professionals engaging in discussions, answering questions and sharing accurate evidence-based information about osteoporosis and bone health with community members.
"We are thrilled with the launch of the WebMD Osteoporosis Exchange featuring experts from NOF," stated Amy Porter, NOF Executive Director and CEO. "The ability to give NOF affiliated healthcare professionals the opportunity to elevate conversations about bone health to the next level is critical to our mission of promoting lifelong bone health and improving the lives of those affected by osteoporosis."
WebMD Health Exchange is now available on WebMD.com.
Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.